Skip to content

Blandine B. Laferrere, M.D.

NPI 1942293899ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· New York, NY

Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in New York, New York, licensed in NY, with an NPI issued in August 2005. Their prescriptions cost Medicare Part D more than their services did: $188,442 for 425 claims, against $11,038 paid for services in 2024. Azurity Pharmaceuticals, Inc. reported $3,120 in payments in 2025, mostly honoraria.

Overview

NPI1942293899
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedAug 25, 2005
Last updated in NPPESOct 15, 2014

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Endocrinology (NY)
Accepts assignmentYes (participating)

Medicare services in 2024

Medicare patients41
Services billed111 across 9 procedure codes
Paid by Medicare$11,038

Part D prescriptions in 2024

Prescriptions (claims)425 · 985 30-day fills
Patients46
Total drug cost$188,442
Generic share50% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$3,120 · 2 payments from 1 company

Top paying companies in 2025

CompanyAmountPayments
Azurity Pharmaceuticals, Inc.$3,1202

What the 2025 payments were for

  • Honoraria$3,120 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other endocrinologists in New York

All 345 endocrinologists in New York · All endocrinologists in New York